Below is Validea's guru fundamental report for QUEST DIAGNOSTICS INC (DGX). Of the 22 guru strategies we follow, DGX rates highest using our Multi-Factor Investor model based on the published ...
StockNews.com lowered shares of Quest Diagnostics (NYSE:DGX – Free Report) from a buy rating to a hold rating in a report ...
Quest Diagnostics Incorporated’s DGX third-quarter 2024 adjusted earnings per share (EPS) of $2.30 beat the Zacks Consensus Estimate by 1.8%. The metric also exceeded the year-ago adjusted ...
Quest Diagnostics Inc.’s DGX third-quarter revenue growth can be attributed to the strong momentum in its expanding portfolio of Advanced Services. The company strategically deploys AI and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback